US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 2.940
  • -0.020-0.68%
Close Apr 24 16:00 ET
  • 2.913
  • -0.027-0.92%
Post 16:00 ET
229.42MMarket Cap73.50P/E (TTM)

Protalix Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
758.12%8.67M
11.02%3.99M
159.60%4.11M
-172.59%-3.61M
239.69%4.19M
94.73%-1.32M
237.69%3.6M
25.16%-6.89M
167.60%4.97M
48.57%-3M
Net income from continuing operations
-64.73%2.93M
207.45%6.49M
274.73%3.24M
-111.39%-2.2M
-46.76%-4.6M
155.68%8.31M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
Operating gains losses
-352.63%-172K
-396.72%-181K
102.78%3K
109.09%1K
-75.00%5K
92.96%-38K
139.35%61K
-325.00%-108K
97.88%-11K
-76.47%20K
Depreciation and amortization
9.49%1.3M
6.71%334K
7.87%329K
8.87%319K
15.00%322K
9.67%1.19M
13.82%313K
11.72%305K
9.33%293K
3.70%280K
Deferred tax
107.63%236K
--0
1,065.79%443K
97.80%-69K
---138K
---3.09M
--0
--38K
---3.13M
--0
Other non cash items
151.67%310K
10.48%137K
483.95%1.15M
-21.74%-504K
-4,181.82%-471K
12.92%-600K
-27.06%124K
-464.15%-299K
39.39%-414K
91.06%-11K
Change In working capital
107.70%811K
-144.34%-3.45M
72.42%-1.67M
81.36%-2.15M
1,251.57%8.08M
12.28%-10.54M
2,491.33%7.77M
4.08%-6.07M
-738.20%-11.54M
84.78%-702K
-Change in receivables
641.36%2.32M
-120.00%-752K
294.50%8.38M
-90.44%-7.05M
-54.33%1.75M
64.15%-428K
-16.41%3.76M
25.33%-4.31M
-254.98%-3.7M
265.21%3.82M
-Change in inventory
1.92%-2.2M
-259.34%-4.04M
280.70%3.52M
143.56%1.63M
5.66%-3.3M
-294.87%-2.24M
213.20%2.54M
-200.15%-1.95M
667.82%668K
-357.28%-3.5M
-Change in payables and accrued expense
-86.86%696K
-7.39%1.37M
-590.96%-869K
-50.97%1.61M
-500.57%-1.41M
210.22%5.3M
503.01%1.48M
-58.45%177K
185.39%3.29M
134.92%353K
-Change in other current assets
-130.77%-4K
-1,800.00%-17K
-177.78%-7K
200.00%6K
55.56%14K
360.00%13K
-96.00%1K
133.33%9K
---6K
--9K
-Change in other working capital
----
----
----
114.05%1.66M
895.32%11.04M
-84.00%-13.18M
--0
--0
-589,600.00%-11.79M
47.54%-1.39M
Cash from discontinued investing activities
Operating cash flow
758.12%8.67M
11.02%3.99M
159.60%4.11M
-172.59%-3.61M
239.69%4.19M
94.73%-1.32M
237.69%3.6M
25.16%-6.89M
167.60%4.97M
48.57%-3M
Investing cash flow
Cash flow from continuing investing activities
125.26%4.22M
-4,379.53%-15.32M
197.36%20.33M
18.92%-180K
-112.81%-606K
-231.90%-16.71M
-106.90%-342K
-453.16%-20.88M
-162.18%-222K
129.11%4.73M
Net PPE purchase and sale
-11.31%-1.28M
-70.00%-425K
81.21%-84K
15.69%-172K
-141.13%-598K
-82.96%-1.15M
-17.37%-250K
-670.69%-447K
-59.38%-204K
-8.30%-248K
Net investment purchase and sale
135.15%5.42M
---15M
----
----
----
-208.40%-15.42M
--0
-440.33%-20.42M
--0
131.25%5M
Net other investing changes
156.34%80K
214.13%105K
25.00%-9K
55.56%-8K
60.00%-8K
-123.95%-142K
-155.42%-92K
60.00%-12K
-103.71%-18K
28.57%-20K
Cash from discontinued investing activities
Investing cash flow
125.26%4.22M
-4,379.53%-15.32M
197.36%20.33M
18.92%-180K
-112.81%-606K
-231.90%-16.71M
-106.90%-342K
-453.16%-20.88M
-162.18%-222K
129.11%4.73M
Financing cash flow
Cash flow from continuing financing activities
-168.09%-16.79M
3.63M
-20.42M
0
0
199.42%24.67M
0
0
10.43M
14.23M
Net issuance payments of debt
---20.42M
--0
----
----
----
--0
----
----
----
----
Net common stock issuance
-84.86%3.63M
--3.63M
--0
--0
--0
190.85%23.95M
--0
--0
--9.72M
--14.23M
Proceeds from stock option exercised by employees
--0
--0
--0
----
----
35,500.00%712K
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-168.09%-16.79M
--3.63M
---20.42M
--0
--0
199.42%24.67M
--0
--0
294.74%10.43M
--14.23M
Net cash flow
Beginning cash position
38.12%23.63M
34.31%27.41M
-51.44%23.4M
-17.64%27.21M
38.12%23.63M
-56.11%17.11M
90.37%20.41M
285.72%48.18M
95.62%33.04M
-56.11%17.11M
Current changes in cash
-158.75%-3.9M
-336.80%-7.7M
114.45%4.01M
-124.96%-3.79M
-77.57%3.58M
130.45%6.64M
-49.31%3.25M
-1,466.99%-27.77M
448.58%15.18M
172.29%15.97M
Effect of exchange rate changes
121.93%25K
300.00%54K
77.78%-2K
44.44%-20K
83.33%-7K
-48.05%-114K
-3.85%-27K
---9K
10.00%-36K
-281.82%-42K
End cash Position
-16.39%19.76M
-16.39%19.76M
34.31%27.41M
-51.44%23.4M
-17.64%27.21M
38.12%23.63M
38.12%23.63M
90.37%20.41M
285.72%48.18M
95.62%33.04M
Free cash flow
399.64%7.39M
6.61%3.57M
154.78%4.02M
-179.30%-3.78M
210.60%3.59M
90.37%-2.47M
218.45%3.35M
20.81%-7.34M
163.72%4.77M
46.42%-3.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 758.12%8.67M11.02%3.99M159.60%4.11M-172.59%-3.61M239.69%4.19M94.73%-1.32M237.69%3.6M25.16%-6.89M167.60%4.97M48.57%-3M
Net income from continuing operations -64.73%2.93M207.45%6.49M274.73%3.24M-111.39%-2.2M-46.76%-4.6M155.68%8.31M-61.60%-6.04M48.08%-1.85M462.56%19.34M-36.96%-3.13M
Operating gains losses -352.63%-172K-396.72%-181K102.78%3K109.09%1K-75.00%5K92.96%-38K139.35%61K-325.00%-108K97.88%-11K-76.47%20K
Depreciation and amortization 9.49%1.3M6.71%334K7.87%329K8.87%319K15.00%322K9.67%1.19M13.82%313K11.72%305K9.33%293K3.70%280K
Deferred tax 107.63%236K--01,065.79%443K97.80%-69K---138K---3.09M--0--38K---3.13M--0
Other non cash items 151.67%310K10.48%137K483.95%1.15M-21.74%-504K-4,181.82%-471K12.92%-600K-27.06%124K-464.15%-299K39.39%-414K91.06%-11K
Change In working capital 107.70%811K-144.34%-3.45M72.42%-1.67M81.36%-2.15M1,251.57%8.08M12.28%-10.54M2,491.33%7.77M4.08%-6.07M-738.20%-11.54M84.78%-702K
-Change in receivables 641.36%2.32M-120.00%-752K294.50%8.38M-90.44%-7.05M-54.33%1.75M64.15%-428K-16.41%3.76M25.33%-4.31M-254.98%-3.7M265.21%3.82M
-Change in inventory 1.92%-2.2M-259.34%-4.04M280.70%3.52M143.56%1.63M5.66%-3.3M-294.87%-2.24M213.20%2.54M-200.15%-1.95M667.82%668K-357.28%-3.5M
-Change in payables and accrued expense -86.86%696K-7.39%1.37M-590.96%-869K-50.97%1.61M-500.57%-1.41M210.22%5.3M503.01%1.48M-58.45%177K185.39%3.29M134.92%353K
-Change in other current assets -130.77%-4K-1,800.00%-17K-177.78%-7K200.00%6K55.56%14K360.00%13K-96.00%1K133.33%9K---6K--9K
-Change in other working capital ------------114.05%1.66M895.32%11.04M-84.00%-13.18M--0--0-589,600.00%-11.79M47.54%-1.39M
Cash from discontinued investing activities
Operating cash flow 758.12%8.67M11.02%3.99M159.60%4.11M-172.59%-3.61M239.69%4.19M94.73%-1.32M237.69%3.6M25.16%-6.89M167.60%4.97M48.57%-3M
Investing cash flow
Cash flow from continuing investing activities 125.26%4.22M-4,379.53%-15.32M197.36%20.33M18.92%-180K-112.81%-606K-231.90%-16.71M-106.90%-342K-453.16%-20.88M-162.18%-222K129.11%4.73M
Net PPE purchase and sale -11.31%-1.28M-70.00%-425K81.21%-84K15.69%-172K-141.13%-598K-82.96%-1.15M-17.37%-250K-670.69%-447K-59.38%-204K-8.30%-248K
Net investment purchase and sale 135.15%5.42M---15M-------------208.40%-15.42M--0-440.33%-20.42M--0131.25%5M
Net other investing changes 156.34%80K214.13%105K25.00%-9K55.56%-8K60.00%-8K-123.95%-142K-155.42%-92K60.00%-12K-103.71%-18K28.57%-20K
Cash from discontinued investing activities
Investing cash flow 125.26%4.22M-4,379.53%-15.32M197.36%20.33M18.92%-180K-112.81%-606K-231.90%-16.71M-106.90%-342K-453.16%-20.88M-162.18%-222K129.11%4.73M
Financing cash flow
Cash flow from continuing financing activities -168.09%-16.79M3.63M-20.42M00199.42%24.67M0010.43M14.23M
Net issuance payments of debt ---20.42M--0--------------0----------------
Net common stock issuance -84.86%3.63M--3.63M--0--0--0190.85%23.95M--0--0--9.72M--14.23M
Proceeds from stock option exercised by employees --0--0--0--------35,500.00%712K--0--0--------
Cash from discontinued financing activities
Financing cash flow -168.09%-16.79M--3.63M---20.42M--0--0199.42%24.67M--0--0294.74%10.43M--14.23M
Net cash flow
Beginning cash position 38.12%23.63M34.31%27.41M-51.44%23.4M-17.64%27.21M38.12%23.63M-56.11%17.11M90.37%20.41M285.72%48.18M95.62%33.04M-56.11%17.11M
Current changes in cash -158.75%-3.9M-336.80%-7.7M114.45%4.01M-124.96%-3.79M-77.57%3.58M130.45%6.64M-49.31%3.25M-1,466.99%-27.77M448.58%15.18M172.29%15.97M
Effect of exchange rate changes 121.93%25K300.00%54K77.78%-2K44.44%-20K83.33%-7K-48.05%-114K-3.85%-27K---9K10.00%-36K-281.82%-42K
End cash Position -16.39%19.76M-16.39%19.76M34.31%27.41M-51.44%23.4M-17.64%27.21M38.12%23.63M38.12%23.63M90.37%20.41M285.72%48.18M95.62%33.04M
Free cash flow 399.64%7.39M6.61%3.57M154.78%4.02M-179.30%-3.78M210.60%3.59M90.37%-2.47M218.45%3.35M20.81%-7.34M163.72%4.77M46.42%-3.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.